Ams Osram Sells Sensors to Infineon for €570m, but the Debt Disconnect Remains Stark

The completion of the non-optical sensor unit sale to Infineon on July 1, 2026 sent Ams Osram shares surging 7.96% to €21.70 on Friday, extending their weekly gain to 14.81%. Yet beneath the surface of that rally lies a fundamental discrepancy over the health of the company’s balance sheet. While the group claims its net leverage has fallen sharply, one of the world’s leading rating agencies sees a far heavier burden — and the gap is wide enough to keep investors on edge.

Infineon paid €570 million for the portfolio of position and temperature sensors plus mixed-signal products, which generated roughly €230 million in annual revenue. Some 230 employees will transfer as part of the deal. For Ams Osram, the transaction does two things: injects much-needed cash into a strained balance sheet and sharpens the strategic focus on the higher-margin photonics business, particularly the Digital Photonics division that analysts now regard as the primary growth engine.

The official arithmetic looks promising. The company states that net debt relative to EBITDA drops from 3.3x to around 2.5x after the Infineon deal. But Fitch Ratings calculates a very different figure. Using a stricter accounting methodology, the agency projects an EBITDA leverage of 6.3x for the end of 2025. That more than doubles the company’s own number and underscores a persistent financial headache that cannot be masked by a single divestiture.

Ams Osram booked a net loss of roughly €154 million in the first quarter of 2026, and the consensus among analysts is for negative earnings per share for the full year. Positive net income is not expected until 2027. To bridge the gap, management has rolled out the “Simplify” restructuring program, targeting annual savings of around €200 million by 2028. Combined with the Infineon sale and other disposals, total divestiture proceeds should reach approximately €670 million. The ultimate goal: turning free cash flow positive in 2027 — but that hinges on a recovery in the automotive cycle and initial commercial wins in AI photonics or augmented-reality applications. Any stumble on one of those fronts could reignite market skepticism in a hurry.

Should investors sell immediately? Or is it worth buying Ams Osram?

Growth hopes rest heavily on Digital Photonics, where analysts see potential revenue of €50 to €100 per smart glasses device. The company is also positioning itself in optical connectivity for AI data centers. Meanwhile, MicroLED technology carries both long-term upside as a stock catalyst and near-term execution risk. The market currently values Ams Osram at around 7.5 times expected EBITDA — a multiple that reflects both the turnaround narrative and the unresolved leverage.

The stock’s trajectory tells a story of extremes. Year-to-date, shares have climbed 155.29%, and over the past twelve months the gain stands at 69%. From the December 2025 low of €7.38, the recovery amounts to a staggering 194.04%. Still, the price remains 18.73% below the 52-week high of €26.70 reached in May. The annualized volatility of 97.48% and a relative strength index of 57.6 suggest that while the rally has room to run without overheating, swings could be violent. The stock now trades 11.52% above its 50-day moving average of €19.46 and a full 78% above its 200-day average of €12.19 — a sign of how dramatically the market has repriced the equity in recent months.

With €570 million in fresh cash, Ams Osram may attract renewed attention from institutional investors. The broader semiconductor sector, boosted by recent chip launches from major U.S. tech companies, could provide additional tailwinds. But the key test lies in the quarters ahead: whether the company can close the chasm between its official leverage of 2.5x and the 6.3x that Fitch sees. The next earnings release will offer the first concrete evidence of whether the recovery story is built on solid ground or just accounting optics.